000 | 00952 a2200313 4500 | ||
---|---|---|---|
005 | 20250511152735.0 | ||
264 | 0 | _c19770216 | |
008 | 197702s 0 0 eng d | ||
022 | _a0047-6706 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHadden, J W | |
245 | 0 | 0 |
_aAntimetabolites and the central nervous system. _h[electronic resource] |
260 |
_bClinical bulletin _c1976 |
||
300 |
_a116-7 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xmetabolism |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCentral Nervous System _xmetabolism |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aFolic Acid Antagonists _xmetabolism |
650 | 0 | 4 | _aHaplorhini |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia _xdrug therapy |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aMice |
773 | 0 |
_tClinical bulletin _gvol. 6 _gno. 3 _gp. 116-7 |
|
999 |
_c834079 _d834079 |